🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

some heads up, The EMBO Workshop "CRISPR-Cas: from biology to therapeutic applications", to be held from 2–5 November 2025 in Sorrento Italy. Please retweet #CRISPR Stay tuned for the programe and registration here 👇 coming-soon.embo.org/w25-86

A new Commentary co-authored with Panicos Shangaris, PhD has just been published in Molecular Therapy. It accompanies an important paper published in the same journal by Miccio lab . To access the Commentary, see link below: authors.elsevier.com/a/1k7lu5QliS5B…

Thank you John and Panicos for this nice commentary!

insights.bio/cell-and-gene-…

Discussing "Ex Vivo Genetic Modification and Hematopoietic Cell Transplantation" at the ASH Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies ASH

Nouvelle publication scientifique ! Importance des études de sécurité et d'efficacité pour le traitement de la drépanocytose par CRISPR-Cas9, pour en savoir plus 👉 institutimagine.org/fr/importance-…

Discussing Gene therapy for β-thalassemia: current and future options sciencedirect.com/science/articl…

Drs. Giulia Hardouin, Annarita Miccio (Miccio lab), and Mégane Brusson review breakthroughs in gene addition- and genome-editing-based therapies for β-thalassemia and more. Check it out! bit.ly/40otJ9U

Treating Sickle Cell Disease: Gene Therapy Approaches | Annual Reviews - go.shr.lc/40Mg3XO

𝐍𝐞𝐰 𝐓𝐫𝐢𝐩𝐥𝐞-𝐀𝐜𝐭𝐢𝐨𝐧 𝐂𝐑𝐈𝐒𝐏𝐑 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐄𝐧𝐚𝐛𝐥𝐞𝐬 𝐒𝐢𝐦𝐮𝐥𝐭𝐚𝐧𝐞𝐨𝐮𝐬 𝐆𝐞𝐧𝐞 𝐀𝐜𝐭𝐢𝐯𝐚𝐭𝐢𝐨𝐧, 𝐑𝐞𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐃𝐞𝐥𝐞𝐭𝐢𝐨𝐧 𝐢𝐧 𝐏𝐫𝐢𝐦𝐚𝐫𝐲 𝐇𝐮𝐦𝐚𝐧 𝐓 𝐂𝐞𝐥𝐥𝐬 Scientists at Aarhus University have developed a

Med Sci (Paris) 2025; 41 : 33–39 Une approche CRISPR/Cas pour traiter les β-hémoglobinopathies A CRISPR/Cas approach to β-haemoglobinopathies Megane Brusson* et Annarita Miccio** medecinesciences.org/en/articles/me…

Read our commentary on Cell Stem Cell: Two is better than one: Advancing gene therapy protocols for enhanced safety and efficacy Cell Stem Cell sciencedirect.com/science/articl…

🧬 Cost Action GenE-Humdi COST Action, con la colaboración de SETGyC, organiza el curso "Optimizing Gene Editing with Advanced Omics: Safety, Off-Target Detection, and Cell Phenotyping", que se celebrará del 11 al 14 de marzo de 2025 en GENYO (Granada, España). ¡Y ofrecen becas! 🧵1/3

Happy to participate in the Keystone symposia "Precision Genome Engineering: Translating the Human Genome to the Clinic" #KSGenomeEng25 and share our latest results!

L’Institut Imagine est un exemple de réussite à la française dans le domaine de l’innovation en santé. L’IHU incarne l’excellence. Excellence dans l’innovation pour mieux comprendre et soigner les maladies rares et génétiques, avec 99 familles brevets actifs, Excellence dans

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury go.nature.com/41ZCoRj

Check out our recent collaborative study on how inflammation influences stem cell engraftment in beta-hemoglobinopathies! Bravo Steicy Sobrino Emmanuelle Six !!! nature.com/articles/s4146…

Bye-bye #ASGCT2025 . It was a pleasure to chair the session on Advanced editing tools with Tj Cradick TJ Cradick organized by the genome editing committee!@ASGCTherapy

We're thrilled to be organizing a CRISPR-Cas9 workshop in the beautiful city of Sorrento, featuring renowned scientists from around the globe! meetings.embo.org/event/25-crisp…

It was great to attend the first Genother summit 2025 meeting!Thank you Genother #genother #GenoTherSummit #genetherapy